Martin J. Gilligan
Corporate Officer/Principal bei PHATHOM PHARMACEUTICALS, INC.
Aktive Positionen von Martin J. Gilligan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06.01.2020 | - |
Karriereverlauf von Martin J. Gilligan
Ehemalige bekannte Positionen von Martin J. Gilligan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
Ausbildung von Martin J. Gilligan
| Providence College | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Martin J. Gilligan
- Erfahrung
